Type 1 Diabetes: Competitive Landscape to 2026

Tuesday, October 30, 2018 Diabetes News
Email Print This Page Comment bookmark
Font : A-A+

LONDON, Oct. 29, 2018 /PRNewswire/ -- Type 1 Diabetes: Competitive Landscape to 2026SummaryType 1 Diabetes

(T1D) is an autoimmune disease that permanently destroys beta cells of the pancreatic islet, which means that the body can no longer produce insulin. Type 1 Diabetes (T1D) can develop at any age, but is frequently observed in children and adolescents.Type
1 Diabetes (T1D) is the seventh most investigated indication within metabolic diseases by number of clinical trials, accounting for 8% of all clinical trials initiated since 1995.Download the full report: https://www.reportbuyer.com/product/5601849 Globally, Type 1 Diabetes (T1D) pipeline features 236 products across all stages of clinical development, with insulin and small molecules prominently featured in Phase III. Insulins, vaccines, and monoclonal antibodies dominate the early-stage pipeline.Multiple big pharma developers (Novo Nordisk, Eli Lilly, and Sanofi) are investigating "smart insulin," insulin that can detect and respond to glucose levels. And for Stem Cell Therapy research, big pharma once again has a large presence, with AstraZeneca, Johnson and Johnson, Novo Nordisk, and Sanofi gearing up to develop novel treatments that target diabetes.Overall, it is expected that new insulins and SGLT inhibitor approvals will drive Type 1 Diabetes market growth during the next decade.The report "Type 1 Diabetes: Competitive Landscape to 2026", provides an assessment of the pipeline, clinical, and commercial landscape of Type 1 Diabetes along with an analysis of key market events and the future competitive environment.ScopeThis report combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.Components of the slide deck include -- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics- Commercial Assessment: leading marketed products, current and future players- Competitive Landscape Analysis: key market events (2016-2026).Reasons to buy- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.- Develop business strategies by understanding the trends shaping and driving the global Type 1 Diabetes (T1D) market.- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Type 1 Diabetes (T1D) market in the future.- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.Download the full report: https://www.reportbuyer.com/product/5601849 About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: sarah@reportbuyer.com Tel: +1 (718) 213 4904 Website: www.reportbuyer.com

Cision View original content:http://www.prnewswire.com/news-releases/type-1-diabetes-competitive-landscape-to-2026-300739668.html

SOURCE ReportBuyer

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store